DIAEGYPT 2025: Empowering the Future of Diabetes Care Through Science and Connection

From October 1–3, 2025, Cairo became the center of global dialogue on diabetes and metabolic medicine as DIAEGYPT 2025 convened at the InterContinental Citystars Hotel. Hosted by leading experts in endocrinology and diabetology, this year’s edition advanced the discussion from treatment to transformation — where data, innovation, and empathy converge to redefine patient care.

Expertly organized by ICOM Group, the three-day congress delivered an immersive scientific experience with parallel sessions, joint society symposia, and accredited lectures that united the medical community under one shared vision: empowering better outcomes for people living with diabetes.

Numbers That Tell a Story

• 2,034 physical attendees

• 579 virtual participants

• 145 faculty guests, including 21 international experts

• 23 scientific sessions

• 25 accredited hours (AACME Category 1)

These figures reflect more than participation — they represent the growing regional influence of DIAEGYPT as one of the largest diabetes congresses in the Middle East.

Exploring the Science That Shapes Tomorrow

DIAEGYPT 2025’s program offered a panoramic view of current and emerging research in diabetes management, bringing the latest evidence to the forefront of clinical practice.

Highlights included:

• Memorial Lectures honoring pioneers of diabetes care in

• Joint Society Sessions with international associations from the UK, Greece, Spain, and Italy — bridging global expertise with local insight.

• Workshops and Rising Stars sessions, where young physicians shared cutting-edge research and clinical innovations.

• Symposia with leading pharmaceutical partners, unveiling advancements in cardio-renal-metabolic therapeutics, GLP-1 receptor agonists, and novel digital approaches to diabetes care.

Every lecture, discussion, and panel carried a clear message: the future of diabetes care is collaborative, data-driven, and deeply human.

A Gathering of Minds and Missions

Throughout the congress, participants experienced a rare balance between scientific depth and open dialogue. From managing diabetic foot and obesity to redefining diabesity as a “modern metabolic syndrome,” the sessions emphasized how multidisciplinary collaboration remains the foundation of improved outcomes.

“DIAEGYPT has grown beyond a congress — it has become a movement that unites experts to exchange, question, and create the next era of diabetes care.”

This sentiment resonated across halls, where the exchange of perspectives between

clinicians, researchers, and industry innovators underscored the event’s lasting impact.

Recognizing Excellence in Education

The Accreditation Review Committee (ARC) of the American Association of Continuing Medical Education® (AACME) designated DIAEGYPT 2025 as an accredited educational activity with 19.25 hours in Category 1 credit.

This certification reaffirmed the congress’s academic integrity and its alignment with global standards of continuing medical education — a testament to ICOM Group’s excellence in executing compliant, world-class scientific events.

Moments That Defined DIAEGYPT 2025

The conference wasn’t just about data and discussions — it was about people, progress, and purpose. From interactive sessions and practical workshops to the energy of collaboration in every corridor, DIAEGYPT 2025 captured what modern medicine stands for: connection and compassion powered by knowledge.

Each interaction told a story of commitment — of experts determined to improve lives through science, empathy, and teamwork.

The Road Ahead

As DIAEGYPT 2025 concluded, it left behind a blueprint for future editions: one rooted in innovation, partnership, and education.

Behind every detail — from scientific flow and speaker coordination to digital integration — stood ICOM Group, ensuring precision, professionalism, and a delegate experience worthy of an international benchmark.

DIAEGYPT 2025 was not just an event; it was a celebration of progress in diabetes care

— and a promise to continue driving change, one discovery at a time.